Goh, C. Y. & Ronco, C. Cardio-renal syndromes [J]. J. Ren. Care 36(Suppl 1), 9–17 (2010).
Ronco, C. et al. Cardiorenal syndrome [J]. J. Am. Coll. Cardiol. 52(19), 1527–1539 (2008).
Ahmed, M. S., Wong, C. F. & Pai, P. Cardiorenal syndrome – a new classification and current evidence on its management [J]. Clin. Nephrol. 74(4), 245–257 (2010).
Drazner, M. H. et al. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure [J]. N. Engl. J. Med. 345(8), 574–581 (2001).
Jain, P. et al. Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization [J]. Am. Heart J. 145(2 Suppl), S3-17 (2003).
Androne, A. S. et al. Hemodilution is common in patients with advanced heart failure [J]. Circulation 107(2), 226–229 (2003).
Godin, M., Bouchard, J. & Mehta, R. L. Fluid balance in patients with acute kidney injury: emerging concepts [J]. Nephron Clin. Pract. 123(3–4), 238–245 (2013).
Laakso, M. & Kuusisto, J. Insulin resistance and hyperglycaemia in cardiovascular disease development [J]. Nat. Rev. Endocrinol. 10(5), 293–302 (2014).
Alberti, K. G. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J]. Circulation 120(16), 1640–1645 (2009).
Williams, K. V. et al. Can clinical factors estimate insulin resistance in type 1 diabetes? [J]. Diabetes 49(4), 626–632 (2000).
Penno, G. et al. Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study [J]. BMC Med 19(1), 66 (2021).
Nyström T, Holzmann M J, Eliasson B, et al. Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes [J]. Diabetes, obesity & metabolism, 2018, 20(3): 556–63.
Chen H Y, Kuo S, Su P F, et al. Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up [J]. Diabetes care, 2020, 43(8): 1732–40.
Orchard, T. J. et al. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study [J]. Kidney Int. 62(3), 963–970 (2002).
Mao, Y. & Zhong, W. Changes of insulin resistance status and development of complications in type 1 diabetes mellitus: Analysis of DCCT/EDIC study [J]. Diabetes Res Clin Pract 184, 109211 (2022).
Dong B, Chen Y, Yang X, et al. Estimated glucose disposal rate outperforms other insulin resistance surrogates in predicting incident cardiovascular diseases in cardiovascular-kidney-metabolic syndrome stages 0–3 and the development of a machine learning prediction model: a nationwide prospective cohort study [J]. Cardiovascular Diabetology, 2025, 24(1).
Tao S, Yu L, Li J, et al. Insulin resistance quantified by estimated glucose disposal rate predicts cardiovascular disease incidence: a nationwide prospective cohort study [J]. Cardiovascular Diabetology, 2025, 24(1).
Finfer, S. et al. Intensive versus conventional glucose control in critically ill patients [J]. N. Engl. J. Med. 360(13), 1283–1297 (2009).
Aramendi I, Burghi G, Manzanares W. Dysglycemia in the critically ill patient: current evidence and future perspectives [J]. Revista Brasileira de Terapia Intensiva, 2017, 29(3).
Krinsley J S, Schultz M J, Spronk P E, et al. Mild hypoglycemia is independently associated with increased mortality in the critically ill [J]. Critical Care, 2011, 15(4).
Lou, J. et al. A retrospective study utilized MIMIC-IV database to explore the potential association between triglyceride-glucose index and mortality in critically ill patients with sepsis [J]. Sci. Rep. 14(1), 24081 (2024).
Johnson, A. E. W. et al. MIMIC-IV, a freely accessible electronic health record dataset [J]. Sci Data 10(1), 1 (2023).
Nyström T, Holzmann M J, Eliasson B, et al. Estimated glucose disposal rate and long-term survival in type 2 diabetes after coronary artery bypass grafting [J]. Heart and vessels, 2017, 32(3): 269–78.
Jin, A. et al. Mediation of Systemic Inflammation on Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke [J]. Stroke 54(3), 759–769 (2023).
Da Silva A A, Do Carmo J M, Li X, et al. Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited [J]. The Canadian journal of cardiology, 2020, 36(5): 671–82.
Fu C, Li Y, Gao X, et al. Association between estimated glucose disposal rate with the all-cause and cause-specific mortality among the population with cardiometabolic syndrome [J]. Diabetology & metabolic syndrome, 2025, 17(1).
Xing, D. et al. Correlation between estimated glucose disposal rate, insulin resistance, and cardiovascular mortality among individuals with metabolic syndrome: a population-based analysis, evidence from NHANES 1999–2018 [J]. Diabetol. Metab. Syndr. 17(1), 11 (2025).
Chen, X., Li, A. & Ma, Q. Association of estimated glucose disposal rate with metabolic syndrome prevalence and mortality risks: a population-based study [J]. Cardiovasc Diabetol 24(1), 38 (2025).
Kong X, Wang W. Estimated glucose disposal rate and risk of cardiovascular disease and mortality in U.S. adults with prediabetes: a nationwide cross-sectional and prospective cohort study [J]. Acta Diabetologica, 2024, 61(11): 1413–21.
Wang H, Zhou Z, Liu X, et al. Gender differences in the association between insulin resistance assessed by estimated glucose disposal rate and the risk of all-cause and cardiovascular deaths in adults without diabetes [J]. Diabetes Research and Clinical Practice, 2025, 219.
Peng J, Li A, Yin L, et al. Estimated Glucose Disposal Rate Predicts Renal Progression in Type 2 Diabetes Mellitus: A Retrospective Cohort Study [J]. Journal of the Endocrine Society, 2023, 7(7).
Karamanakos, G. et al. The association of insulin resistance measured through the estimated glucose disposal rate with predictors of micro-and macrovascular complications in patients with type 1 diabetes [J]. Prim. Care Diabetes 16(6), 837–843 (2022).
Brealey, D. & Singer, M. Hyperglycemia in critical illness: a review [J]. J. Diabetes Sci. Technol. 3(6), 1250–1260 (2009).
Krinsley, J. S. et al. Mild hypoglycemia is independently associated with increased mortality in the critically ill [J]. Critical care (London, England) 15(4), R173 (2011).
Wei, M. et al. Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality [J]. Circulation 101(17), 2047–2052 (2000).
Ichai C, Preiser J-C. International recommendations for glucose control in adult non diabetic critically ill patients [J]. Critical Care, 2010, 14(5).
Adler, G. K. et al. Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control [J]. Diabetes 58(2), 360–366 (2009).
Damman, K. et al. Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH) [J]. Eur. J. Heart Fail. 11(9), 847–854 (2009).
van Hooijdonk, R. T. et al. Sweet Spot: Glucose Control in the Intensive Care Unit [J]. Seminars in respiratory and critical care medicine 37(1), 57–67 (2016).
Preiser J-C, van Zanten A R H, Berger M M, et al. Metabolic and nutritional support of critically ill patients: consensus and controversies [J]. Critical Care, 2015, 19(1).
